|Values are valid only on day of printing.|
Assessing accidental fluoride ingestion
Monitoring patients receiving sodium fluoride for bone disease or patients receiving voriconazole therapy
Fluoride induces bone formation by stimulating osteoblasts. Because fluorides increase bone density, they are used in dental preparations and as an antiosteoporotic agent. However, prolonged high exposure to fluoride produces changes in bone morphology consistent with osteomalacia, including prolonged mineralization lag time and increased osteoid thickness. The adverse skeletal effects of fluoride are associated with plasma fluoride >4 mcmol/L. Chronic fluorosis may produce osteosclerosis, periostitis, calcification of ligaments and tendons, and crippling deformities.
Prolonged exposure to the fluoride-containing antifungal agent voriconazole can produce high plasma fluoride concentrations and bone changes (periostitis).
Humans exposed to fluoride-treated water typically have plasma fluoride in the range of 1 to 4 mcmol/L. Those who are not drinking fluoride-treated water have plasma fluoride <1 mcmol/L. Plasma fluoride values >4 mcmol/L indicate excessive exposure and are associated with periostitis.
In solutions of below pH 5, H(+) complexes with the fluoride ion, thus reducing the free fluoride ion concentration and giving a falsely low reading.
At higher pH (>9), the hydroxyl ion (OH-) will interfere with electrodes, giving a falsely elevated reading.
Specimen must be sent in a plastic vial.
1. Cardos VES, Whitford GH, Aoyama H, et al: Daily variations in human plasma fluoride concentrations. J Fluorine Chem 2008:129;1193-1198
2. Wermers RA, Cooper K, Razonable RR, et al: Long term use of voriconazole, a fluoride containing medication, is associated with periostitis, fluorosis, and fluoride excess in transplant patients. Clin Infect Dis 2011;52:604-611